Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Inflammatory cytokine-mediated evasion of virus-induced tumors from NK cell control.

Mishra R, Polic B, Welsh RM, Szomolanyi-Tsuda E.

J Immunol. 2013 Jul 15;191(2):961-70. doi: 10.4049/jimmunol.1203328. Epub 2013 Jun 14.

2.

NK cells and gammadelta T cells mediate resistance to polyomavirus-induced tumors.

Mishra R, Chen AT, Welsh RM, Szomolanyi-Tsuda E.

PLoS Pathog. 2010 May 27;6(5):e1000924. doi: 10.1371/journal.ppat.1000924.

3.

Activating receptor NKG2D targets RAE-1-expressing allogeneic neural precursor cells in a viral model of multiple sclerosis.

Weinger JG, Plaisted WC, Maciejewski SM, Lanier LL, Walsh CM, Lane TE.

Stem Cells. 2014 Oct;32(10):2690-701. doi: 10.1002/stem.1760.

4.

Natural killer cells recognize friend retrovirus-infected erythroid progenitor cells through NKG2D-RAE-1 interactions In Vivo.

Ogawa T, Tsuji-Kawahara S, Yuasa T, Kinoshita S, Chikaishi T, Takamura S, Matsumura H, Seya T, Saga T, Miyazawa M.

J Virol. 2011 Jun;85(11):5423-35. doi: 10.1128/JVI.02146-10. Epub 2011 Mar 16.

5.

Fratricide of natural killer cells dressed with tumor-derived NKG2D ligand.

Nakamura K, Nakayama M, Kawano M, Amagai R, Ishii T, Harigae H, Ogasawara K.

Proc Natl Acad Sci U S A. 2013 Jun 4;110(23):9421-6. doi: 10.1073/pnas.1300140110. Epub 2013 May 20.

6.

NKG2D blockade inhibits poly(I:C)-triggered fetal loss in wild type but not in IL-10-/- mice.

Thaxton JE, Nevers T, Lippe EO, Blois SM, Saito S, Sharma S.

J Immunol. 2013 Apr 1;190(7):3639-47. doi: 10.4049/jimmunol.1203488. Epub 2013 Mar 1.

7.

Antiviral T-cell-independent type 2 antibody responses induced in vivo in the absence of T and NK cells.

Szomolanyi-Tsuda E, Brien JD, Dorgan JE, Garcea RL, Woodland RT, Welsh RM.

Virology. 2001 Feb 15;280(2):160-8.

8.

Leishmania-infected macrophages are targets of NK cell-derived cytokines but not of NK cell cytotoxicity.

Prajeeth CK, Haeberlein S, Sebald H, Schleicher U, Bogdan C.

Infect Immun. 2011 Jul;79(7):2699-708. doi: 10.1128/IAI.00079-11. Epub 2011 Apr 25.

9.

Inhibition of NK cell activity through TGF-beta 1 by down-regulation of NKG2D in a murine model of head and neck cancer.

Dasgupta S, Bhattacharya-Chatterjee M, O'Malley BW Jr, Chatterjee SK.

J Immunol. 2005 Oct 15;175(8):5541-50.

10.

Evasion from NK cell immunity by MHC class I chain-related molecules expressing colon adenocarcinoma.

Doubrovina ES, Doubrovin MM, Vider E, Sisson RB, O'Reilly RJ, Dupont B, Vyas YM.

J Immunol. 2003 Dec 15;171(12):6891-9.

11.

NKG2D ligation relieves 2B4-mediated NK-cell self-tolerance in mice.

Lee JE, Lim SA, Kim TJ, Kim K, Ng J, Kim YH, Jang IJ, Oh SB, Lee JC, Yee C, Kumar V, Lee KM.

Eur J Immunol. 2014 Jun;44(6):1802-13. doi: 10.1002/eji.201343724. Epub 2014 Apr 16.

12.
13.

NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules.

Lodoen M, Ogasawara K, Hamerman JA, Arase H, Houchins JP, Mocarski ES, Lanier LL.

J Exp Med. 2003 May 19;197(10):1245-53.

14.

Intact NKG2D-independent function of NK cells chronically stimulated with the NKG2D ligand Rae-1.

Champsaur M, Beilke JN, Ogasawara K, Koszinowski UH, Jonjic S, Lanier LL.

J Immunol. 2010 Jul 1;185(1):157-65. doi: 10.4049/jimmunol.1000397. Epub 2010 Jun 7.

15.

CD4(+) NKG2D(+) T cells induce NKG2D down-regulation in natural killer cells in CD86-RAE-1ε transgenic mice.

Lin Z, Wang C, Xia H, Liu W, Xiao W, Qian L, Jia X, Ding Y, Ji M, Gong W.

Immunology. 2014 Mar;141(3):401-15. doi: 10.1111/imm.12203.

16.
17.

NK cell-extrinsic IL-18 signaling is required for efficient NK-cell activation by vaccinia virus.

Brandstadter JD, Huang X, Yang Y.

Eur J Immunol. 2014 Sep;44(9):2659-66. doi: 10.1002/eji.201344134. Epub 2014 Jun 17.

18.

Critical role of the NKG2D receptor for NK cell-mediated control and immune escape of B-cell lymphoma.

Belting L, Hömberg N, Przewoznik M, Brenner C, Riedel T, Flatley A, Polić B, Busch DH, Röcken M, Mocikat R.

Eur J Immunol. 2015 Sep;45(9):2593-601. doi: 10.1002/eji.201445375. Epub 2015 Jul 7.

19.

Requirements for control of B-cell lymphoma by NK cells.

Brenner CD, King S, Przewoznik M, Wolters I, Adam C, Bornkamm GW, Busch DH, Röcken M, Mocikat R.

Eur J Immunol. 2010 Feb;40(2):494-504. doi: 10.1002/eji.200939937.

20.

Long-lasting T cell-independent IgG responses require MyD88-mediated pathways and are maintained by high levels of virus persistence.

Raval FM, Mishra R, Garcea RL, Welsh RM, Szomolanyi-Tsuda E.

MBio. 2013 Nov 5;4(6):e00812-13. doi: 10.1128/mBio.00812-13.

Supplemental Content

Support Center